Variable/cohort | Overall mortality | Cardiovascular mortality | Liver-related mortality | Diabetes-related mortality |
Age | 1.09* (1.06 to 1.12) | 1.10* (1.05 to 1.15) | 1.06* (1.01 to 1.11) | 1.10* (1.02 to 1.19) |
Male gender | 2.39* (1.32 to 4.33) | 8.45* (2.46 to 29.00) | 2.66 (0.94 to 7.55) | 0.42 (0.13 to 1.34) |
White | 0.80 (0.37 to 1.76) | 0.22 (0.07 to 0.68) | 1.57 (0.48 to 5.18) | 0.86 (0.17 to 4.37) |
Smoking | 2.39 (0.94 to 6.04) | 1.75 (0.44 to 7.04) | 0.18 (0.02 to 2.19) | 3.29 (0.17 to 65.36) |
Excessive alcohol | 1.69 (0.64 to 4.47) | 2.67 (0.36 to 19.70) | 0.26 (0.03 to 2.15) | 10.46* (3.28 to 33.35) |
Type 2 siabetes | 1.12 (0.37 to 3.36) | 1.61 (0.35 to 7.46) | 2.20 (0.97 to 3.84) | 5.41* (1.35 to 84.60) |
Insulin resistance | 0.81 (0.22 to 2.99) | 1.52 (0.47 to 4.94) | 3.48* (1.10 to 11.01) | 21.55* (1.41 to 328.12) |
Hypercholesterolaemia | 1.16 (0.55 to 2.45) | 1.01 (0.33 to 3.08) | 0.16 (0.03 to 0.83) | 5.21* (1.04 to 26.12) |
Hypertension | 2.81 (0.87 to 9.12) | 15.20* (1.40 to 165.55) | 5.17* (1.18 to 22.73) | 0.12 (NA) |
Obesity | 1.41 (0.47 to 4.27) | NA | 11.16* (1.80 to 69.17) | 0.18 (0.00 to 24.20) |
Metabolic syndrome | 1.67 (0.63 to 4.45) | NA | 3.38* (1.52 to 6.66) | 85.43* (2.86 to 2551.67) |
↵* p Value for the adjusted HR (aHR) is ≤0.05.
NA, not available because of insufficient sample size.